[Neonatal herpes simplex hepatitis with favorable outcome after treatment with acyclovir].
BACKGROUND
Herpes simplex virus (HSV) may cause severe disease in the neonate with high mortality and devastating sequellae. This infection presents exceptionally as isolated fulminant hepatitis.


METHODS
An 8 day-old baby was admitted because of seizures, fever and vomiting. Initial investigations including CSF analysis were negative and the patient was given ampicillin plus netilmicin. Two skin vesicles were seen 5 days later containing HSV. A second CSF analysis was negative as was the brain scan. At that time, liver involvement was evident: ASAT 3700 IU/l; ALAT 1035 IU/l; prothrombin 37%; fibrinogen 1 g/l. Hemogram showed WBC: 2,500/mm3 and PNN: 702/mm3. The patient was given acyclovir 40 mg/kg/day IV. Blood and CSF culture remained negative; CSF interferon concentration was 4 IU/ml. Serologic investigations in both parents were inconclusive. The disease worsened rapidly with consumption coagulopathy requiring ventilation support. The dose of acyclovir was increased to 60 mg/kg/day, 9 days after admission. Improvement was noted on the 10th day and acyclovir was administered orally on the 21st day. The condition was completely normal 6 months later.


CONCLUSIONS
Early administration of acyclovir may favor complete recovery of neonatal HSV hepatitis.
Service de néonataologie et réanimation néonatale, CHG de Saint-Pierre, Le Tampon, France.
H
H
Pilorget
C
C
Estoup
J B
JB
Mariette
A
A
Fourmaintraux
D000212:Acyclovir / Q000008:administration & dosage / Q000627:therapeutic use*; D000284:Administration, Oral; D006525:Hepatitis, Viral, Human / Q000188:drug therapy*; D006561:Herpes Simplex / Q000188:drug therapy*; D006801:Humans; D007231:Infant, Newborn; D007275:Injections, Intravenous; D008297:Male
D000212:Acyclovir
Hépatite herpétique néonatale d'évolution favorable sous aciclovir.